Nigel J Pyne (N J Pyne)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Combination Therapy

Tyrosine Kinase

Coronary Artery

Top Venues

The Journal of pharmacology and experimental therapeutics

International journal of molecular sciences

University of Strathclyde

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Strathclyde

United Kingdom

Professor :: Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS)

Publications

Sun-Hye Shin, Hee-Yeon Kim, Hee-Soo Yoon, Woo-Jae Park, David R Adams, Nigel J Pyne, Susan Pyne, Joo-Won Park
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes. International journal of molecular sciences 21 (21) (2020)
Nigel J Pyne, Susan Pyne
Recent advances in the role of sphingosine 1-phosphate in cancer. FEBS letters 594 (22) (2020)
H Alganga, T A M Almabrouk, O J Katwan, C J Daly, Susan Pyne, Nigel J Pyne, Simon Kennedy
Short Periods of Hypoxia Upregulate Sphingosine Kinase 1 and Increase Vasodilation of Arteries to Sphingosine 1-Phosphate (S1P) via S1P3. The Journal of pharmacology and experimental therapeutics 371 (1) (2019)